AUTUMN SHIVER: Open Payments
NPI 1477097319 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 95 payments from 19 companies in 2025. Trend: 2023 $2,295 · 2024 $2,133 · 2025 $1,831
Food & beverage: $1,831
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $402 |
| Lilly USA, LLC | 14 | $181 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $175 |
| Novo Nordisk Inc | 11 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $145 |
| GlaxoSmithKline, LLC. | 6 | $127 |
| Amgen Inc. | 6 | $106 |
| PFIZER INC. | 5 | $99 |
| Astellas Pharma US Inc | 3 | $79 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
Products named: FARXIGA, JARDIANCE, Kerendia, MOUNJARO, AIRSUPRA, AREXVY, BREZTRI, Veozah.
Industry payments across GA — which companies pay providers there.
